Literature DB >> 18008245

Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response.

Lorna Maclean1, Martin Odiit, Annette Macleod, Liam Morrison, Lindsay Sweeney, Anneli Cooper, Peter G E Kennedy, Jeremy M Sternberg.   

Abstract

We describe 2 spatially distinct foci of human African trypanosomiasis in eastern Uganda. The Tororo and Soroti foci of Trypanosoma brucei rhodesiense infection were genetically distinct as characterized by 6 microsatellite and 1 minisatellite polymorphic markers and were characterized by differences in disease progression and host-immune response. In particular, infections with the Tororo genotype exhibited an increased frequency of progression to and severity of the meningoencephalitic stage and higher plasma interferon (IFN)- gamma concentration, compared with those with the Soroti genotype. We propose that the magnitude of the systemic IFN- gamma response determines the time at which infected individuals develop central nervous system infection and that this is consistent with the recently described role of IFN- gamma in facilitating blood-brain barrier transmigration of trypanosomes in an experimental model of infection. The identification of trypanosome isolates with differing disease progression phenotypes provides the first field-based genetic evidence for virulence variants in T. brucei rhodesiense.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18008245      PMCID: PMC2082664          DOI: 10.1086/522011

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Minisatellite marker analysis of Trypanosoma brucei: reconciliation of clonal, panmictic, and epidemic population genetic structures.

Authors:  A MacLeod; A Tweedie; S C Welburn; I Maudlin; C M Turner; A Tait
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  The detection of geographical substructuring of Trypanosoma brucei populations by the analysis of minisatellite polymorphisms.

Authors:  A MacLeod; C M Turner; A Tait
Journal:  Parasitology       Date:  2001-11       Impact factor: 3.234

3.  Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis.

Authors:  B Namangala; W Noël; P De Baetselier; L Brys; A Beschin
Journal:  J Infect Dis       Date:  2001-05-15       Impact factor: 5.226

4.  Cytokines and the acute phase response in post-treatment reactive encephalopathy of Trypanosoma brucei brucei infected mice.

Authors:  P D Eckersall; J W Gow; C McComb; B Bradley; J Rodgers; M Murray; P G Kennedy
Journal:  Parasitol Int       Date:  2001-03       Impact factor: 2.230

5.  Nitric oxide and cytokine synthesis in human African trypanosomiasis.

Authors:  L MacLean; M Odiit; J M Sternberg
Journal:  J Infect Dis       Date:  2001-09-28       Impact factor: 5.226

6.  The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda.

Authors:  E M Fèvre; P G Coleman; M Odiit; J W Magona; S C Welburn; M E Woolhouse
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

7.  T lymphocyte-triggering factor of african trypanosomes is associated with the flagellar fraction of the cytoskeleton and represents a new family of proteins that are present in several divergent eukaryotes.

Authors:  K L Hill; N R Hutchings; P M Grandgenett; J E Donelson
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

8.  Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment.

Authors:  V Lejon; J Lardon; G Kenis; L Pinoges; D Legros; S Bisser; X N'Siesi; E Bosmans; P Büscher
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 May-Jun       Impact factor: 2.184

9.  Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury.

Authors:  Milena Penkowa; Mercedes Giralt; Natalia Lago; Jordi Camats; Javier Carrasco; Joaquin Hernández; Amalia Molinero; Iain L Campbell; Juan Hidalgo
Journal:  Exp Neurol       Date:  2003-06       Impact factor: 5.330

10.  Use of multiple displacement amplification to increase the detection and genotyping of trypanosoma species samples immobilized on FTA filters.

Authors:  Liam J Morrison; Gillian McCormack; Lindsay Sweeney; Anne C L Likeufack; Philippe Truc; C Michael Turner; Andy Tait; Annette MacLeod
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

View more
  40 in total

1.  Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.

Authors:  Natalia Tiberti; Alexandre Hainard; Veerle Lejon; Xavier Robin; Dieudonné Mumba Ngoyi; Natacha Turck; Enock Matovu; John Enyaru; Joseph Mathu Ndung'u; Alexander Scherl; Loïc Dayon; Jean-Charles Sanchez
Journal:  Mol Cell Proteomics       Date:  2010-08-19       Impact factor: 5.911

2.  Phylogeography and taxonomy of Trypanosoma brucei.

Authors:  Oliver Balmer; Jon S Beadell; Wendy Gibson; Adalgisa Caccone
Journal:  PLoS Negl Trop Dis       Date:  2011-02-08

3.  Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection.

Authors:  Liam J Morrison; Sarah McLellan; Lindsay Sweeney; Chi N Chan; Annette MacLeod; Andy Tait; C Michael R Turner
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 4.  Traversal of human and animal trypanosomes across the blood-brain barrier.

Authors:  Dennis J Grab; Peter G E Kennedy
Journal:  J Neurovirol       Date:  2008-11-18       Impact factor: 2.643

5.  Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.

Authors:  Lorna MacLean; Hansotto Reiber; Peter G E Kennedy; Jeremy M Sternberg
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

Review 6.  Parasite-driven pathogenesis in Trypanosoma brucei infections.

Authors:  L J Morrison
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

7.  The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense.

Authors:  Smiths Lueong; Smiths Leong; Gustave Simo; Mamadou Camara; Vincent Jamonneau; Jacques Kabore; Hamidou Ilboudo; Bruno Bucheton; Jörg D Hoheisel; Christine Clayton
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

8.  Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.

Authors:  Lorna M MacLean; Martin Odiit; John E Chisi; Peter G E Kennedy; Jeremy M Sternberg
Journal:  PLoS Negl Trop Dis       Date:  2010-12-07

9.  A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.

Authors:  Alexandre Hainard; Natalia Tiberti; Xavier Robin; Veerle Lejon; Dieudonné Mumba Ngoyi; Enock Matovu; John Charles Enyaru; Catherine Fouda; Joseph Mathu Ndung'u; Frédérique Lisacek; Markus Müller; Natacha Turck; Jean-Charles Sanchez
Journal:  PLoS Negl Trop Dis       Date:  2009-06-16

10.  A major genetic locus in Trypanosoma brucei is a determinant of host pathology.

Authors:  Liam J Morrison; Andy Tait; Sarah McLellan; Lindsay Sweeney; C Michael R Turner; Annette MacLeod
Journal:  PLoS Negl Trop Dis       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.